Corrigendum to "Protective effect of hsa-miR-570-3p targeting CD274 on triple negative breast cancer by blocking PI3K/AKT/mTOR signaling pathway" [Kaohsiung J Med Sci. 2020;36(8):581-591]

Kaohsiung J Med Sci. 2022 Mar;38(3):288. doi: 10.1002/kjm2.12525.

Authors

Li-Li Wang¹, Wei-Wei Huang¹, Jing Huang², Rong-Fang Huang³, Na-Ni Li¹, Yi Hong¹, Mu-Lan Chen¹, Fan Wu¹, Jian Liu¹

Affiliations

¹ Department of Medical Oncology, Fujian Cancer Hospital & Fujian Medical University Cancer Hospital, Fuzhou, Fujian Province, China.
² Department of Pharmacy, Fujian Cancer Hospital & Fujian Medical University Cancer Hospital, Fuzhou, Fujian Province, China.
³ Department of Pathology, Fujian Cancer Hospital & Fujian Medical University Cancer Hospital, Fuzhou, Fujian Province, China.

PMID: 35286015
DOI: 10.1002/kjm2.12525

No abstract available

Publication types

Published Erratum